EICHOR
● Active Not Recruiting
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma · Sponsor: Duke University
About this study
ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| State University of Iowa | Iowa City, Iowa, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| Ochsner Clinic Foundation d/b/a Ochsner Health | New Orleans, Louisiana, United States | — |
| The Johns Hopkins University | Baltimore, Maryland, United States | — |
| The Regents of the University of Michigan | Ann Arbor, Michigan, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | — |
| Duke University | Durham, North Carolina, United States | — |
| The Ohio State University | Columbus, Ohio, United States | — |
| Geisinger Clinic | Danville, Pennsylvania, United States | — |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | — |
| The University of Texas Southwestern Medical Center | Dallas, Texas, United States | — |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04919122